These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2699466)

  • 21. A double-blind comparison of a microcrystalline theophylline tablet and salbutamol in reversible airways obstruction.
    Tedders JG; Thomas AK; Edwards G
    Br J Clin Pract; 1976; 30(11-12):212-6. PubMed ID: 795447
    [No Abstract]   [Full Text] [Related]  

  • 22. [Delayed-release salbutamol, a new beta-mimetic with prolonged action. Results of a comparative study against theophylline L.A].
    Brune J; Desfougères JL
    Allerg Immunol (Paris); 1991 Oct; 23(8):358-64. PubMed ID: 1777051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction.
    Sahay JN; Chatterjee SS; Summerfield PJ
    Br J Clin Pract; 1986 May; 40(5):198-202. PubMed ID: 2944533
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
    Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
    Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease.
    Gimeno F; Steenhuis EJ; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerability of doxofylline in the maintenance therapy of pediatric patients with bronchial asthma.
    Bagnato GF
    Eur Rev Med Pharmacol Sci; 1999; 3(6):255-60. PubMed ID: 11261736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylxanthine drug therapy in chronic heart failure associated with hypoxaemia: double-blind placebo-controlled clinical trial of doxofylline versus theophylline and bamifylline.
    Dini FL; Pasini G; Cortellini G; Cani E; Bettini R; Garagnani A; Gobbi G; Greco A; Onorato G; Pasini P
    Int J Clin Pharmacol Res; 1993; 13(6):305-16. PubMed ID: 8088931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
    Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
    Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Systemic cardiorespiratory effects induced by doxofylline].
    Bagnato GF; Allegra A; De Leo A; Giacobbe MS; Mileto A; Cinquegrani M; Leotta G; Buemi AL; Spina E; Scibilia M
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):29-35. PubMed ID: 2798988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease.
    Shukla D; Chakraborty S; Singh S; Mishra B
    Expert Opin Pharmacother; 2009 Oct; 10(14):2343-56. PubMed ID: 19678793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conclusion without support - remarks on 'Efficacy and safely of doxyphyllin compared to Theophylline in chronic reversible asthma- a double-blind randomized placebo-controlled multicentre trial' by Goldstein MF, Chervinsky P (published in MedSciMonit, 2002; 8(4):CR297-304.
    Bense L
    Med Sci Monit; 2002 Aug; 8(8):LE27-8. PubMed ID: 12229856
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].
    Ukena D; Koper I; Braun H; Leutz M; Schlimmer P; Sybrecht GW
    Pneumologie; 1997 Mar; 51(3):317-23. PubMed ID: 9173422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
    Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.